PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Feb-2024 Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK-861, an Oral Orexin Agonist, in Narcolepsy Type 1 in First Half of Fiscal Year 2024 Businesswire
09-Feb-2024 ACI: NYC Bill to Restrict Safe Detergent Chemistry is Unnecessary, Would Disrupt Sustainable Innovation Businesswire
09-Feb-2024 Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2023 Businesswire
09-Feb-2024 Aptar Reports Fourth Quarter and Annual 2023 Results Businesswire
09-Feb-2024 AdaptHealth Corp. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call Businesswire
09-Feb-2024 Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 Businesswire
09-Feb-2024 Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations Businesswire
08-Feb-2024 Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage Businesswire
08-Feb-2024 MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
08-Feb-2024 Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2024 Businesswire
08-Feb-2024 X-FAB Fourth Quarter and Full Year 2023 Results Businesswire
08-Feb-2024 Samsung Launches New Women’s Health Online Resource at SMFM 2024 Pregnancy Meeting Businesswire
08-Feb-2024 GE HealthCare and MedQuest Associates Collaborate to Provide Innovative Medical Device Technology and Digital Tools for Outpatient Imaging Centers Businesswire
08-Feb-2024 Paige Expands its AppLab Marketplace with Six New Digital Pathology Providers to Deliver a More Robust and Streamlined User Experience for Diagnosing Cancer Businesswire
08-Feb-2024 Aizon Secures $20M in Series C Funding Led by NewVale Capital to Enhance Pharma Manufacturing Outcomes Businesswire
08-Feb-2024 Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product Newswire
08-Feb-2024 Linden Capital Partners and Ontario Teachers’ Pension Plan Launch Initiative Focused on Clinical Research Advancement Businesswire
08-Feb-2024 Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology Businesswire
08-Feb-2024 Resource Label Group announces new specialty business unit – RLG Healthcare Businesswire
08-Feb-2024 A Practical Guide to Producing and Maintaining the Pharmacovigilance System Master File (PSMF) Training Course (ONLINE EVENT) - ResearchAndMarkets.com Businesswire